Eli Lilly (LLY 1.15%) and Novo Nordisk (NVO 0.14%) are two phenomenal growth stocks that investors probably can't go wrong ...

Obesity medications, once facing shortages, are now widely available. So how do consumers not get scammed into purchasing ...

In the most recent trading session, Eli Lilly (LLY) closed at $786.92, indicating a +1.19% shift from the previous trading day.

Shares of Eli Lilly & Co. LLY rose 1.19% to $786.92 Wednesday, on what proved to be an all-around great trading session for ...

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the future.

Hims and Hers announced this morning that it will begin offering compounded semaglutide (generic Ozempic or Wegovy) for $199 ...

The country’s biggest pharmaceuticals group pointed to “specific non-allied countries” and urged the White House to ...

UBS has reiterated its Buy rating and $1,050 price target on LLY stock, highlighting the company’s growing dominance in the ...

The weight-loss drug boom has dominated headlines for the last two years — but underneath the hype lies a major flaw in the ...

Irish-made medicines heading to the US face steep new duties, raising alarm among patients, producers and investors on both ...

United States President Donald Trump upped the stakes in his global trade war on Tuesday, with the announcement of plans to impose a 50 percent tariff on all imported copper alongside a 20 percent ...

A little over a year after celebrating its 30th anniversary in China with a major production upgrade, Novo Nordisk is back ...